Dr. Mark A. Kontos, MD
- Medicare services, 2024
- 1,476
- Medicare patients, 2024
- 439
- Part D claims, 2024
- 833
- Clinical trials
- 1
- MIPS score, 2024
- 90
- Practice address
- 1475 Nw 12th Ave, Miami, FL 33136
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Kontos' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark A. Kontos is an ophthalmologist in Miami, Florida
Dr. Kontos practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.
Dr. Kontos' NPI, 1114938990, was assigned on August 10, 2006. Dr. Kontos holds Washington license 30698.
- NPI
- 1114938990NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5799784369
- NPI enumeration date
- August 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 68
- Medical school graduation
- 1984
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark A. Kontos practices at Sylvester Comprehensive Cancer Center in Miami, Florida
Dr. Kontos' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.
- Sylvester Comprehensive Cancer Center1475 Nw 12th Ave, Miami, FL 33136
Source: Dmand AI Affiliation Data
Dr. Mark A. Kontos is affiliated with 2 sites of care and 2 medical groups
Dr. Kontos' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Kontos to 1 more ambulatory surgery center and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mark A. Kontos' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kontos practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sylvester Comprehensive Cancer Center | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Miami and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark A. Kontos is one of 1,398 ophthalmologists in Florida
Ophthalmology is Dr. Kontos' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Kontos' licenses on file in 2 states: Washington and Idaho.
Specialties and state licenses
- Ophthalmology, WashingtonPrimary
- Idaho license
Ophthalmologists near Dr. Kontos
Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark A. Kontos billed Medicare for 1,476 services in 2024
CMS data shows 1,476 Medicare services from Dr. Kontos across 11 procedure codes in 2024, for 439 Medicare patients. Medicare paid $159,994 for them.
Dr. Kontos' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Tests and treatments
- 2023: 6262024: 6534%
- Office and hospital visits
- 2023: 4932024: 5359%
- Surgery
- 2023: 3062024: 2886%
Where Dr. Kontos' Medicare services took place, 2024
- In an office1,20181%
- In a facility27519%
Dr. Kontos compared with the Florida median for ophthalmologists, 2024
- Dr. Kontos
- Florida median
- Medicare services
- 1,476vs 1,69913% below
- Medicare patients
- 439vs 55721% below
- Part D claims
- 774vs 8185% below
Medians across 1,345 ophthalmologists in Florida with Dmand AI profiles that report each measure.
Dr. Kontos' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kontos?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kontos and other ophthalmologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark A. Kontos treated 439 Medicare patients in 2024, average age 76
CMS counts 439 Medicare patients who saw Dr. Kontos in 2024. The largest group is 75 to 84, with 210 patients. 64% of them have high cholesterol, and 59% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Kontos' median patient age at 75, with 55% women.
Dr. Kontos' Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Kontos' Medicare patients by sex, 2024
- Women25257%
- Men18743%
Chronic conditions among Dr. Kontos' Medicare patients, 2024
- High cholesterol64%
- High blood pressure59%
- Arthritis42%
- Diabetes17%
- Ischemic heart disease17%
- Cancer16%
- Atrial fibrillation15%
- Chronic kidney disease15%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kontos' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women55%
- Men45%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mark A. Kontos wrote 833 Medicare Part D claims in 2024
In 2024, Dr. Kontos wrote 833 Medicare Part D claims for 232 patients. 64% of them were for generic drugs. CMS names the drug for 774 of them, across 7 drugs with 11 or more claims each, at $20,624 in total drug cost. In 2023, CMS named 685 claims across 7 drugs.
Dr. Kontos' Part D claims by kind of drug, 2024
- Generic529 claims64%
- Brand-name304 claims36%
Dr. Kontos' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6852024: 77413%
Drugs named by CMS: 7 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mark A. Kontos scored 90 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Kontos for performance year 2024, reported as part of a group. Dr. Kontos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 89 procedures of cataract surgery by Dr. Kontos, more than 73% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
Dr. Kontos' MIPS scores, performance year 2024
- 90of 100Final score
- 88.7of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 77of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Kontos ranks in Medicare procedure volume
- Cataract surgery
- 73rd percentile89 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark A. Kontos has worked on 1 clinical trial
Dmand AI links Dr. Kontos to 1 clinical trial. Conditions studied include Dilatation, Pathologic and Keratoconus.
Conditions in Dr. Kontos' trials
- Dilatation, Pathologic
- Keratoconus
Investigators on the most trials with Dr. Kontos
- Gregg Jonathan Berdy, MD1 shared trial
- Carlos Buznego, MD1 shared trial
- Jonathan M. Davidorf, MD1 shared trial
Recent clinical trials with Dr. Kontos
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark A. Kontos received $261,341 in industry payments from 2016 to 2025
CMS Open Payments shows 587 general payments to Dr. Kontos from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $99,883.
General payments to Dr. Kontos by program year, 2016 to 2025
General payments to Dr. Kontos by kind, 2016 to 2025
- Consulting fees$190,47973%
- Food and beverage$30,07112%
- Speaker and faculty fees$21,1188%
- Honoraria$9,3764%
- Other$10,0844%
Companies that paid Dr. Kontos the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Mark A. Kontos's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark A. Kontos
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark A. Kontos' NPI number?
Dr. Mark A. Kontos' NPI number is 1114938990. It was assigned on August 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark A. Kontos?
Dr. Mark A. Kontos is an ophthalmologist in Miami, Florida. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).
Where does Dr. Mark A. Kontos practice?
Dr. Kontos practices at 1475 Nw 12th Ave, Miami, FL 33136. Dr. Kontos' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dmand AI also links Dr. Kontos to 1 ambulatory surgery center and 1 medical group.
What is Dr. Mark A. Kontos' medical license number?
Dr. Kontos holds Washington license 30698, one of the licenses on file in 2 states.
Which states has Dr. Mark A. Kontos been licensed in?
Dmand AI has state licenses on file for Dr. Kontos in Washington and Idaho.
Which hospitals is Dr. Mark A. Kontos affiliated with?
Dr. Kontos practices at Sylvester Comprehensive Cancer Center in Miami, Florida.
What medical group is Dr. Mark A. Kontos part of?
Dr. Kontos is linked to University of Miami Health System. Dmand AI links Dr. Kontos to 1 more medical group.
Does Dr. Mark A. Kontos accept Medicare?
Yes. CMS data shows Dr. Kontos billed Medicare for 1,476 services in 2024, and Dr. Kontos accepts Medicare assignment.
What is Dr. Mark A. Kontos' MIPS score?
Dr. Kontos' MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.
How many Medicare patients does Dr. Mark A. Kontos see?
CMS counts 439 Medicare patients who saw Dr. Kontos in 2024, with an average age of 76.
Show 5 more questionsShow fewer questions
What services does Dr. Mark A. Kontos bill to Medicare?
In 2024, Dr. Kontos' most billed Medicare services were office visit, established patient (99214), eye exam or test (92136) and surgery: eye (66984).
What drugs does Dr. Mark A. Kontos prescribe most?
In 2024 Medicare Part D data, Dr. Kontos' most prescribed drugs by claims were Ketorolac Tromethamine, Prednisolone Acetate and Ofloxacin.
Has Dr. Mark A. Kontos received payments from drug or device companies?
CMS Open Payments shows $261,341 in general payments to Dr. Kontos from 37 companies from 2016 to 2025. The largest total came from Johnson & Johnson Surgical Vision, Inc.
How long has Dr. Mark A. Kontos been practicing?
Dr. Kontos graduated from medical school in 1984, 42 years ago.
Does Dr. Mark A. Kontos do research?
Dr. Kontos has worked on 1 clinical trial.
Selling to ophthalmology practices?
See ophthalmologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card